Tacrolimus decreases tubular phosphate wasting in renal allograft recipients

Transplantation Proceedings

Volumn 35, Issue 6, 2003, Pages 2213-2215

  Falkiewicz, Krzysztof ^a,b   Nahaczewska, W ^a   Boratynska, M ^a   Owczarek, H ^a   Klinger, M ^a   Kaminska, D ^a   Wozniak, M ^a   Szepietowski, T ^a   Patrzalek, D ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Dept of Nephrology/Transplant Med ^*  (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; AZATHIOPRINE; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CYCLOSPORIN A; PARATHYROID HORMONE; PREDNISONE; TACROLIMUS; VITAMIN D;

ADOLESCENT; ADULT; BLOOD ANALYSIS; CADAVER KIDNEY; CALCIUM BLOOD LEVEL; CALCULATION; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE DISORDER; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PRIORITY JOURNAL; SIDE EFFECT; TUBULAR DYSFUNCTION;

EID: 0141504068     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00765-6     Document Type: Conference Paper

References (4)

1. Levi M. Kidney Int. 59:2001;2377.
2. Murer H., Forster I., Milfiker M., et al. Kidney Int. 65:(suppl):1998;S2.
3. Walton J., Bijovet O.L.M. Lancet. ii:1975;209.
4. Demeule M., Beliveau R. Am J Physiol. 260:1991;F518.